Efficacy of early intravenous landiolol, an ultrashort-acting beta-blocker on infarct size and its safety in patients with myocardial infarction undergoing primary PCI: a randomized, controlled study
Event: ESC Congress 2020
Topic: Reperfusion and Reperfusion Injury
Session: Acute Coronary Syndromes ePosters
